LC
MLAB icon

Lindbrook Capital’s Mesa Laboratories MLAB Stock Holding History

Lindbrook Capital’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4
Closed -$519 – 2863
2024
Q3 		$519 Buy
+4
New +$470 ﹤0.01% 2652
2024
Q1 		– Sell
-6
Closed -$629 – 2719
2023
Q4 		$629 Buy
+6
New +$585 ﹤0.01% 2554
2023
Q3 		– Sell
-4
Closed -$512 – 2773
2023
Q2 		$514 Buy
+4
New +$610 ﹤0.01% 2508
2023
Q1 		– Sell
-2
Closed -$332 – 2861
2022
Q4 		$332 Sell
2
-4
-67% -$627 ﹤0.01% 2658
2022
Q3 		$1K Buy
+6
New +$1.09K ﹤0.01% 2405
2022
Q2 		– Sell
-1
Closed – – 2654
2022
Q1 		$0 Buy
+1
New +$272 ﹤0.01% 2563

Other funds holding MLAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lindbrook Capital's MLAB Position: Q4 2024 in Review

Lindbrook Capital sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 4 shares — an estimated $519 sold.

Lindbrook Capital first reported a position in MLAB in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • Lindbrook Capital reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • Lindbrook Capital sold 4 Mesa Laboratories shares in Q4 2024, an estimated $519.
  • Lindbrook Capital first reported a position in Mesa Laboratories in Q1 2022 and held it in 6 quarters.
  • Lindbrook Capital's Mesa Laboratories position peaked at $1K in Q3 2022.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.